Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 2131038-11-2
- Molecular formula
- C2810H4296N776O882S32
- Molecular weight
- 64090 g/mol
- Drug class
- Long-acting basal insulin analogueantidiabetic hormone
- Mechanism of action
- Activates insulin receptors to regulate glucose metabolism, increasing peripheral glucose uptake (especially in skeletal muscle and adipose tissue) and suppressing hepatic glucose production. Its prolonged weekly action reflects reduced renal clearance, FcRn binding and reduced insulin-receptor affinity relative to human insulin.
- Indications / reported uses
- Improvement of glycaemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise, under the current product label.
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e02229e-262c-4e25-9240-9e9de4eb7c1d · https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-once-weekly-insulin-type-2-diabetes-mellitus · https://www.ema.europa.eu/en/medicines/human/EPAR/onswik